Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents

Carcinogenesis

Volumn 19, Issue 4, 1998, Pages 567-573

  Dosch, Jörg ^a   Christmann, Markus ^a   Kaina, Bernd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT;

ARTICLE; BINDING AFFINITY; CELL SURVIVAL; DNA TRANSFECTION; DRUG RESISTANCE; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKYLATING AGENTS; ANIMALS; CELL CYCLE; CHO CELLS; CRICETINAE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; METHYLATION; MUTS HOMOLOG 2 PROTEIN; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 0031843622     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.4.567     Document Type: Article

References (51)

1. Singer,B. and Grunberger,D. (1983) Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York and London.
2. Kaina,B., Fritz,G., Eschbach,E., Dosch,J. and Preuss,I. (1995) Transfer of genes affecting resistance of mammalian cells to alkylating drugs -implications for cancer chemotherapy. In. Zeller,W.J. and Eisenbrand,G. (eds) Reduction of Anticancer Drug Toxicity. Contr. Oncology. Basel, Karger, vol. 48, pp. 125-141.
3. Bartsch,H. and Montesano,R. (1984) Relevance of nitrosamines to human cancer. Carcinogenesis, 5, 1381-1393.
4. Peto,R., Gray,R., Bantom,P. and Grosso,P. (1985) N-nitroso compounds: Occurrence, Biological Effects and Relevance to Human Cancer, vol. 57. IARC Scientific Publications, Lyon, France, pp. 627-655.
5. Marnett,L.J. and Burcham,P.C. (1993) Endogenous DNA adducts: potential and paradox, Chem. Rex. Toxicol., 6, 771-785.
6. Colvin,M. (1982) The alkylating agents. In Chabner,B. (ed.) Pharmacologic Principles of Cancer Treatment.W.B. Saunders, London, pp. 276-308.
7. Avril,M.F., Bonneterre,J., Delaunay,M. et al. (1990) Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma: experience of the French study group. Pharmacology, 27, 81-84.
8. Beranek,D.T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Rex., 231, 11-30.
9. 6-alkyl-guanine. FASEB J., 6, 2302-2310.
10. Mitra,S. and Kaina,B. (1993) Regulation of repair of alkylation damage in mammalian genomes. Progr. Nucl. Acids Res. Mol. Biol., 44, 109-142.
11. Day,R.S.III, Ziolkowski,C.H.J., Scudiero,D.A., Meyer,S.A., Lubiniecki, A.S., Girardi,A.J., Galloway,S.M. and Bynum,G.D. (1980) Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature, 288, 724-727.
12. Brennand,J. and Margison,G.P. (1986) Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene. Proc. Natl Acad. Sci. USA, 83, 6292-6296.
13. 6-methylguanine and methylphosphotriesters to the cytotoxicity of alkylating agents in mammalian cells. Carcinogenesis. 9, 1587-1593.
14. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis, 12, 1857-1867.
15. 6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines. Env. Mol. Mutagen., 22, 283-292.
16. 6-Methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl Acad. Sci. USA, 90, 6468-6472.
17. 6-alkylguanine-DNA alkyltransferase. Science. 259, 219-222.
18. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage carcinogenesis. Cancer Res., 56, 3244-3249.
19. 6-methylguanine in template DNA during in vitro DNA replication. J. Biol. Chem., 259, 8095-8100.
20. 6-alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature, 223, 206-207.
21. 6-methylguanine built into a unique site in viral genome. Proc. Natl Acad. Sci. USA, 81, 6271-6275.
22. Kaina,B. and Aurich,O. (1985) Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction. Mutat. Res., 149, 451-461.
23. Zhukovskaya,N., Branch,P., Aquilina,G. and Karran,P. (1994) DNA replication arrest and tolerance to DNA methylation damage. Carcinogenesis, 15, 2189-2194.
24. Karran,P. and Bignami,M. (1992) Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucl. Acids Res., 20, 2933-2940.
25. Branch,P., Aquilina,G., Bignami,M. and Karran,P. (1993) Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature, 362, 652-654.
26. Goldmacher,V.S., Cuzick,R.A. and Thilly,W.G. (1986) Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem., 261, 12462-12471.
27. 6-methylguanine-DNA methyltransferase-proficient CHO cells. Carcinogenesis, 9, 1217-1222.
28. Goth-Goldstein,R. and Hughes,M. (1987) Characterization of a CHO variant in respect to alkylating agent-induced biological effects and DNA repair. Mutat. Res., 184, 139-146.
29. Kaina,B., van Zeeland,A.A., Backendorf,C., Thielmann,H.W. and van de Putte,P. (1987) Transfer of human genes conferring resistance to methylating mutagens, but not to UV irradiation and cross-linking agents, into Chinese hamster ovary cells. Mol. Cell. Biol., 7, 2024-2030.
30. Kaina,B. (1987) Correction of alkylation hypersensitivity of CHO-27-1 cells by transfection with human DNA. Carcinogenesis, 8, 1935-1938.
31. Fritz,G., Dosch,J., Thielmann,H.W. and Kaina,B. (1993) Molecular and cellular characterization of Mex-/methylation-resistant phenotype. J. Biol. Chem., 268, 21102-21112.
32. Kat,A., Thilly,W.G., Fang,W.-H., Longley,M.J., Li,G.-M. and Modrich,P. (1993) An alkylation-tolerant mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl Sci. USA, 90, 6424-6428.
33. Risinger,J.I., Umar,A., Barrett,J.C. and Kunkel,T.A. (1995) A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J. Biol. Chem., 270, 18183-18186.
34. Branch,P., Hampson,R. and Karran,P. (1995) DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res., 55, 2304-2309.
35. Marra,G. and Boland,C.R. (1995) Hereditary non-polyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl Cancer Inst., 87, 1114-1125.
36. Kolodner,R. (1996) Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev., 10, 1433-1442.
37. Bradford,M.M. (1976) A rapid and sensitive method for quantitation of proteins utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
38. Stein,B., Rahmsdorf,H.J., Steffen,A., Litfin,M. and Herrlich,P. (1989) UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol., 9, 5169-5181.
39. Fort,P., Marty,L., Piechaczyk,M., El Sabrouty,S., Dani,C., Jeanteur,P. and Blanchard,J.M. (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl. Acids Res., 13, 1431-1442.
40. Scherer,S.J., Seib,T., Seitz,G., Dooley,S. and Welter,C. (1996) Isolation and characterization of the human mismatch repair gene hMSH2 promoter region. Hum. Genet., 97, 114-116.
41. Graham,F.L. and van der Erb,A.J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
42. Fukuda,M., Viitala,J., Matteson,J. and Carlsson,S.R. (1988) Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. J. Boil. Chem., 263, 18920-18928.
43. Aquilina,G., Zijono,A., Moscufo,N., Dogliotti,E. and Bignami,M. (1989) Tolerance to methylnitrosourea-induced DNA damage is associated with 6-thioguanine resistance in CHO cells. Carcinogenesis, 10, 1219-1223.
44. + and methylation tolerant mismatch repair compromised cells: facts and models. Mutat. Res., 381, 227-241.
45. Merrick,W.C. (1992) Mechanism and regulation of eukaryotic protein synthesis. Micmbiol. Rev., 56, 291-315.
46. Pardee,A.B. (1994) Multiple molecular levels of cell cycle regulation. J. Cell. Biochem., 54, 375-378.
47. Griffin,S., Branch,P., Xu,Y.-Z. and Karran,P. (1994) DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry, 33, 4787-1793.
48. Swann,P.F., Waters,T.R., Moulton,D.C. Xu,Y.-Z., Zheng,Q., Edwards,M. and Mace,R. (1996) Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science, 273, 1109-1111.
49. de Wind,N., Dekker,M., Berns,A., Radman,M. and te Riele,H. (1995) Inactivalion of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell, 82, 321-330.
50. Aquilina,G., Hess,P., Branch,P., MacGeoch,C., Casciano,I., Karran,P. and Bigami,M. (1994) A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc. Natl Sci. USA, 91, 8905-8909.
51. Liu,B., Parsons,R., Papadopoulos,N. et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med., 2, 169-174.